Literature DB >> 23090916

MRI of cardiac iron overload.

Winnie C W Chu1, Wing Y Au, Wynnie W M Lam.   

Abstract

Transfusion therapy has greatly improved the survival of transfusion dependent thalassemia major (TM) patients; however, the resultant iron load damages tissues including the heart, liver and endocrine organs. Among these, heart complication still remains the leading cause of mortality. Myocardial iron deposition can occur independently of other solid organ involvement; conversely, the heart may be spared despite heavy siderosis in other tissues. Iron chelation treatment diminishes the risk of hemosiderosis; however, the chelation treatment has its own toxicities and might not be available to all patients due to costs. Close monitoring of individual organ iron concentration and function is thus important for optimization of individual patient care. This review outlines the importance and clinical significance of recently available MRI techniques for monitoring cardiac iron load.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23090916     DOI: 10.1002/jmri.23628

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  10 in total

1.  Comparison of myocardial T1 and T2 values in 3 T with T2* in 1.5 T in patients with iron overload and controls.

Authors:  Gabriel C Camargo; Tamara Rothstein; Flavia P Junqueira; Elsa Fernandes; Andreas Greiser; Ralph Strecker; Viviani Pessoa; Ronaldo S L Lima; Ilan Gottlieb
Journal:  Int J Hematol       Date:  2016-02-12       Impact factor: 2.490

2.  Role of CMR feature-tracking derived left ventricular strain in predicting myocardial iron overload and assessing myocardial contractile dysfunction in patients with thalassemia major.

Authors:  Vineeta Ojha; Kartik P Ganga; Tulika Seth; Ambuj Roy; Nitish Naik; Priya Jagia; Gurpreet S Gulati; Sanjeev Kumar; Sanjiv Sharma
Journal:  Eur Radiol       Date:  2021-03-15       Impact factor: 5.315

3.  MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients.

Authors:  Diana X Nichols-Vinueza; Matthew T White; Andrew J Powell; Puja Banka; Ellis J Neufeld
Journal:  Am J Hematol       Date:  2014-04-10       Impact factor: 10.047

Review 4.  Quantification of liver iron with MRI: state of the art and remaining challenges.

Authors:  Diego Hernando; Yakir S Levin; Claude B Sirlin; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2014-03-03       Impact factor: 4.813

5.  Whole-heart chemical shift encoded water-fat MRI.

Authors:  Valentina Taviani; Diego Hernando; Christopher J Francois; Ann Shimakawa; Karl K Vigen; Scott K Nagle; Mark L Schiebler; Thomas M Grist; Scott B Reeder
Journal:  Magn Reson Med       Date:  2013-11-01       Impact factor: 4.668

6.  Naotaifang extract treatment results in increased ferroportin expression in the hippocampus of rats subjected to cerebral ischemia.

Authors:  Jun Liao; Xing Xia; Guo-Zuo Wang; Yong-Mei Shi; Jin-Wen Ge
Journal:  Mol Med Rep       Date:  2015-02-06       Impact factor: 2.952

7.  Cardiac and Hepatic T2*-Weighted Magnetic Resonance Imaging in Transfusion Dependent Hemoglobinopathy in North West of Iran.

Authors:  N Valizadeh; V Alinejad; S Hejazi; M Noroozi; A Hashemi; B Rahimi; Sh Nateghi
Journal:  Iran J Ped Hematol Oncol       Date:  2015-12-10

8.  Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior.

Authors:  Shahla Ansari; Azita Azarkeivan; Ghasem Miri-Aliabad; Saeed Yousefian; Tahereh Rostami
Journal:  Caspian J Intern Med       Date:  2017

9.  Free-breathing T2* mapping for MR myocardial iron assessment at 3 T.

Authors:  E E Nazarova; G V Tereshchenko; D A Kupriyanov; N S Smetanina; G A Novichkova
Journal:  Eur Radiol Exp       Date:  2020-04-17

10.  The frequency of hypothyroidism and its relationship with HCV positivity in patients with thalassemia major in southern Iran.

Authors:  Sezaneh Haghpanah; Shohreh Jelodari; Hammdollah Karamifar; Forough Saki; Rahil Rahimi; Vincenzo De Sanctis; Javad Dehbozorgian; Mehran Karimi
Journal:  Acta Biomed       Date:  2018-03-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.